These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1152185)

  • 21. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The integrated concentration of plasma renin activity and aldosterone in essential hypertension.
    Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP
    Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion].
    Klumpp F; Klaus D; Lemke R; Zehner J; Zöfel P
    Klin Wochenschr; 1975 Mar; 53(5):221-9. PubMed ID: 1152349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration.
    Rosenthal J; Boucher R; Nowaczynski W; Genest J
    Can J Physiol Pharmacol; 1968 Jan; 46(1):85-91. PubMed ID: 5642446
    [No Abstract]   [Full Text] [Related]  

  • 25. Body-fluid composition in normal and hypertensive man.
    Bauer JH; Brooks CS
    Clin Sci (Lond); 1982 Jan; 62(1):43-9. PubMed ID: 7035057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin-angiotensin-aldosterone system in the newborn lamb: response to furosemide.
    Siegel SR; Fisher DA
    Pediatr Res; 1977 Jul; 11(7):837-9. PubMed ID: 876706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. System dynamics modeling of renin aldosterone and electrolyte changes induced by furosemide in hypertensive patients.
    Hsieh BS; Kuo YM; Hsieh CH; Lee PW
    Taiwan Yi Xue Hui Za Zhi; 1987 Jan; 86(1):17-26. PubMed ID: 3553421
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular, humoral, and renal effects of phenoxybenzamine in hypertension.
    Ganguly A; Weinberger MH; Fineberg NS
    Am J Kidney Dis; 1983 Mar; 2(5):534-43. PubMed ID: 6299099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysis.
    Takeda R; Morimoto S; Uchida K; Miyamori I
    Acta Endocrinol (Copenh); 1976 Aug; 82(4):715-27. PubMed ID: 947281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
    Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
    Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
    Vierhapper H; Waldhäusl W
    Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
    Corvol P; Houde M; Benguigui L; Tonnelier M; Menard J; Milliez P
    Nouv Presse Med; 1977 Sep; 6(29):2569-72. PubMed ID: 909737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of postural changes and volume depletion on renin-angiotensin system (author's transl)].
    Acuña D; García del Río C; Alba F; Sánchez-Cantalejo E; Osorio C; Quesada T
    Rev Esp Fisiol; 1978 Dec; 34(4):411-6. PubMed ID: 741062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of excessive salt-loading on blood pressure, plasma norepinephrine concentration, plasma renin activity, plasma aldosterone concentration and urinary aldosterone excretion in patients with essential hypertension and normotensive subjects].
    Atarashi K
    Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):38-46. PubMed ID: 6343533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.